The efficacy of ampicillin and Lactobacillus casei rhamnosus in the active management of preterm premature rupture of membranes remote from term
Received 29 May 2014
Accepted for publication 12 June 2014
Published 30 August 2014 Volume 2014:8 Pages 1169—1173
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Salih Burcin Kavak,1 Ebru Kavak,2 Rasit Ilhan,1 Remzi Atilgan,1 Ozgur Arat,1 Ugur Deveci,3 Ekrem Sapmaz1
1Department of Obstetrics and Gynecology, Firat Medical Center, School of Medicine, Firat University, 2Department of Obstetrics and Gynecology, Special Medical Park Hospital, 3Department of Pediatrics, Firat Medical Center, School of Medicine, Firat University, Elazig, Turkey
Background: We aimed to investigate the treatment efficacy of ampicillin prophylaxis accompanied by Lactobacillus casei rhamnosus over the latency period following preterm premature rupture of membranes (PPROM).
Methods: Records of 40 patients who presented with PPROM between 230/7–316/7 weeks were analyzed retrospectively. Patients were divided into two groups: group 1 (n=20), treated with ampicillin; and group 2 (n=20), treated with ampicillin plus L. casei rhamnosus. Clinical and laboratory parameters were compared. Delta (∆) values of each laboratory parameter were calculated by subtracting the value at delivery from the values at admission to the clinic.
Results: Gestational weeks at delivery (28.1±0.3 weeks versus 31.5±0.4 weeks), latency periods (12.3±1.5 days versus 41.4±4.4 days), 5-minute APGAR scores (6.8±0.1 versus 7.8±0.1), and birth weights (1,320±98 g versus 1,947±128 g) were significantly higher in group 2. White blood cell (WBC) (12,820±353/mm3 versus 11,107±298/mm3), and neutrophil counts (10.7±0.5×103/L versus 8.2±0.5×103/L) were significantly lower in group 2 at delivery. The ∆WBC (2,295±74/mm3 versus -798±-406/mm3), ∆C-reactive protein (5±0.04 mg/L versus 1.6±0.2 mg/L), and ∆neutrophil (3±0.2×103/L versus 0.2±-0.1×103/L) were significantly lower in group 2.
Conclusion: It seems that addition of L. casei rhamnosus to ampicillin prolongs the latency period in patients with PPROM remote from term.
Keywords: probiotic, antibiotic, latency period
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]